During the past decade, Central Kentucky Research Associates, Inc. conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 55 clinical trials were completed, i.e. on average, 105.8% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 28 clinical trials were completed. i.e. 127.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Kentucky Research Associates, Inc." #1 sponsor was "Pfizer" with 12 trials, followed by "RAI Services Company" with 7 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 5 trials sponsored, "Jazz Pharmaceuticals" with 4 trials sponsored and "Ology Bioservices" with 4 trials sponsored. Other sponsors include 74 different institutions and companies that sponsored additional 60 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Kentucky Research Associates, Inc." #1 collaborator was "Celerion" with 4 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Advaccine (Suzhou) Biopharmaceuticals Co., Ltd." with 1 trials as a collaborator, "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator and "Astra Zeneca, Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Central Kentucky Research Associates, Inc." are "Smoking Cessation" (9 trials), "Fibromyalgia" (7 trials), "Influenza" (7 trials), "Smoking" (7 trials) and "Tobacco Use" (7 trials). Many other conditions were trialed in "Central Kentucky Research Associates, Inc." in a lesser frequency.

Most popular intervention types in "Central Kentucky Research Associates, Inc." are "Drug" (66 trials), "Biological" (26 trials), "Other" (24 trials), "Device" (6 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (45 trials), "placebo" (6 trials), "Xyrem®" (3 trials), "pregabalin" (3 trials) and "AC2993" (2 trials). Other intervention names were less common.

The vast majority of trials in "Central Kentucky Research Associates, Inc." are 100 trials for "All" genders, 6 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Central Kentucky Research Associates, Inc.". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 97 completed trials in Central Kentucky Research Associates, Inc., 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Central Kentucky Research Associates, Inc., 6 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 17 trials that are defined as “Not Applicable".